Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07223580
PHASE4

A Study Of Corticosteroid On Postoperative Pain After Ureteroscopy For Urinary Calculi

Sponsor: Mayo Clinic

View on ClinicalTrials.gov

Summary

The purpose of this research is to evaluate if corticosteroid (prednisone) after ureteroscopy and placement of the stent will help alleviate postoperative pain control in addition to other normal postoperative pain medications

Official title: Evaluating The Role Of Corticosteroids In Post-Ureteroscopy Recovery For Urinary Calculi

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

90

Start Date

2026-01-23

Completion Date

2027-12-01

Last Updated

2026-02-03

Healthy Volunteers

No

Interventions

DRUG

Corticosteroid

In addition to the standard of care postoperative ureteroscopy medication, participants will be given prednisone 25 mg orally, once a day for 5 days post-surgery.

OTHER

Placebo

In addition to the standard of care postoperative ureteroscopy medication, participants will be given a placebo pill orally, once a day for 5 days post-surgery.

Locations (1)

Mayo Clinic in Arizona

Scottsdale, Arizona, United States